Alexander A. Seelenberger - Feb 15, 2023 Form 4 Insider Report for Vincerx Pharma, Inc. (VINC)

Role
Chief Financial Officer
Signature
By: /s/ Alexander A. Seelenberger
Stock symbol
VINC
Transactions as of
Feb 15, 2023
Transactions value $
$0
Form type
4
Date filed
2/16/2023, 03:05 PM
Previous filing
Nov 17, 2022
Next filing
Aug 14, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VINC Stock Option (right to buy) Award $0 +86K $0.00 86K Feb 15, 2023 Common Stock 86K $1.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests in twenty-four equal monthly installments starting from February 15, 2023.

Remarks:

Represents the 3rd tranche of stock option grants previously approved by the Compensation Committee on August 25, 2022.